6 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... • Giant Cell Arteritis ... (TAK) • Polyarteritis ... Polyangiitis (MPA) • Eosinophilic ... #algorithm #rheumatology
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid Arthritis ... - ACR 2021 Guidelines ... #Arthritis #ACR2021 ... #Guidelines #management ... #treatment #rheumatology
2021 ACR/VF Guidelines for Management of Takayasu Arteritis (TAK)

#Takayasu #Arteritis #TAK #ACR2021 #Management #rheumatology #algorithm #vasculitis
2021 ACR/VF Guidelines ... for Management ... (TAK) #Takayasu ... #Arteritis #TAK ... #rheumatology #
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Takayasus #Arteritis ... #algorithm #rheumatology
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
JAK Inhibitors in ... anti-TNF-apha Efficacy (Rheumatoid ... Arthritis) • ... #Indications #Rheumatology ... #Management
2021 ACR Guidance for Adjusting Immunomodulatory Therapy related to the COVID-19 Vaccine in Patients with Rheumatic
Patients with Rheumatic ... Cyclophosphamide, JAK ... MithuRheum #ACR2021 #Guidelines ... #COVID19 #management ... #rheumatology #